Analystreport

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $17.00 price target on the stock.

Iovance Biotherapeutics, Inc.  (IOVA) 
Last iovance biotherapeutics, inc. earnings: 2/25 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: iovance.com